StockData
Cogent Biosciences, Inc. logo

Cogent Biosciences, Inc. (COGT) stock

COGTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$27.44−1.12 (-3.92%)

Close on Nov 16, 2026Market cap $4.76BP/E –Yield –

Cogent Biosciences operating margin

Operating margin is operating income as a percentage of revenue.

Cogent Biosciences's operating margin for the twelve months ending Dec 31, 2020 was -1044.3%. For fiscal 2020 it was -1044.3%, against -143.0% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 2020-1044.3%−901.3
FY2019Dec 31, 2019-143.0%+226.9
FY2018Dec 31, 2018-369.9%−57.1
FY2017Dec 31, 2017-312.8%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2020Sep 30, 2020-18333.0%−17153.0
Q2 FY2020Jun 30, 2020-1402.1%−1066.2
Q1 FY2020Mar 31, 2020-87.3%+300.5
Q4 FY2019Dec 31, 201914.7%+251.3
Q3 FY2019Sep 30, 2019-1180.0%−662.3
Q2 FY2019Jun 30, 2019-335.9%+230.7
Q1 FY2019Mar 31, 2019-387.8%−73.2
Q4 FY2018Dec 31, 2018-236.6%+87.4
Q3 FY2018Sep 30, 2018-517.7%−210.1
Q2 FY2018Jun 30, 2018-566.6%−276.4
Q1 FY2018Mar 31, 2018-314.7%+17.5
Q4 FY2017Dec 31, 2017-324.1%–
Q3 FY2017Sep 30, 2017-307.6%–
Q2 FY2017Jun 30, 2017-290.2%–
Q1 FY2017Mar 31, 2017-332.2%–

More Cogent Biosciences figures

See a number that looks wrong?